Molecular determinants of WNT9b responsiveness in nephron progenitor cells

被引:11
|
作者
Dickinson, Kyle K. [1 ]
Hammond, Leah C. [2 ]
Karner, Courtney M. [3 ]
Hastie, Nicholas D. [4 ]
Carroll, Thomas J. [5 ]
Goodyer, Paul [2 ,6 ]
机构
[1] McGill Univ, Dept Expt Med, Montreal, PQ, Canada
[2] McGill Univ, Dept Human Genet, Montreal, PQ, Canada
[3] Duke Univ, Sch Med, Dept Orthopaed Surg & Cell Biol, Durham, NC USA
[4] Univ Edinburgh, Med Res Council Human Genet Unit, Edinburgh, Midlothian, Scotland
[5] Univ Texas Southwestern, Dept Mol Biol, Dallas, TX USA
[6] McGill Univ, Ctr Hlth, Dept Paediat, Montreal, PQ, Canada
来源
PLOS ONE | 2019年 / 14卷 / 04期
关键词
WILMS-TUMOR SUPPRESSOR; WNT/BETA-CATENIN; SELF-RENEWAL; STEM-CELLS; KIDNEY; MESENCHYME; LGR5; DIFFERENTIATION; MORPHOGENESIS; RECEPTORS;
D O I
10.1371/journal.pone.0215139
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Primed nephron progenitor cells (NPCs) appear in metanephric mesenchyme by E11.5 and differentiate in response to the inductive WNT9b signal from the ureteric bud. However, the NPC WNT-receptor complex is unknown. We obtained M15 cells from E10.5 mesonephric mesenchyme and systematically analyzed components required for canonical WNT9b-responsiveness. When M15 cells were transfected with a beta-catenin luciferase reporter plasmid, exposure to recombinant WNT9b resulted in minimal luciferase activity. We then analyzed mRNA-expression of WNT-pathway components and identified Fzd1-6 and Lrp6 transcripts but not Rspo1. When M15 cells were treated with recombinant RSPO1 the response to transfected WNT9b was augmented 4.8-fold. Co-transfection of M15 cells with Fzd5 (but no other Fzd family member) further increased the WNT9b signal to 16.8-fold and siRNA knockdown of Fzd5 reduced the signal by 52%. Knockdown of Lrp6 resulted in 60% WNT9b signal reduction. We confirmed Fzd5, Lrp6 and Rspo1 mRNA expression in CITED1(+) NPCs from E15.5 embryonic mouse kidney. Thus, while many WNT signaling-pathway components are present by E10.5, optimum responsiveness of E11.5 cap mesenchyme requires that NPCs acquire RSPO1, FZD5 and LRP6.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Notch pathway activation can replace the requirement for Wnt4 and Wnt9b in mesenchymal-to-epithelial transition of nephron stem cells
    Boyle, Scott C.
    Kim, Mijin
    Valerius, M. Todd
    McMahon, Andrew P.
    Kopan, Raphael
    [J]. DEVELOPMENT, 2011, 138 (19): : 4245 - 4254
  • [2] The role of Wnt9b in kidney tubule maintenance
    Karner, Courtney M.
    Carroll, Thomas J.
    [J]. DEVELOPMENTAL BIOLOGY, 2007, 306 (01) : 304 - 304
  • [3] Canonical Wnt9b signaling balances progenitor cell expansion and differentiation during kidney development
    Karner, Courtney M.
    Das, Amrita
    Ma, Zhendong
    Self, Michelle
    Chen, Chuo
    Lum, Lawrence
    Oliver, Guillermo
    Carroll, Thomas J.
    [J]. DEVELOPMENT, 2011, 138 (07): : 1247 - 1257
  • [4] The role of Wnt9b in epithelial tubule induction and differentiation
    Carroll, Thomas J.
    [J]. FASEB JOURNAL, 2007, 21 (05): : A136 - A136
  • [5] Wnt Family Member 9b (Wnt9b) Is a New Sensitive and Specific Marker for Breast Cancer
    Lu, Shaolei
    Yakirevich, Evgeny
    Yang, Dongfang
    Xiao, Ying
    Wang, Li Juan
    Wang, Yihong
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (12) : 1633 - 1640
  • [6] Stromally Expressed β-catenin Modulates Wnt9b in the Ureteric Epithelium
    Bridgewater, Darren
    Boivin, Felix
    [J]. FASEB JOURNAL, 2015, 29
  • [7] Expression of Wnt9b and activation of canonical Wnt signaling during midfacial morphogenesis in mice
    Lan, Yu
    Ryan, Rosemary C.
    Zhang, Zunyi
    Bullard, Steven A.
    Bush, Jeffrey O.
    Maltby, Kathleen M.
    Lidral, Andrew C.
    Jiang, Rulang
    [J]. DEVELOPMENTAL DYNAMICS, 2006, 235 (05) : 1448 - 1454
  • [8] Utility of Wnt family member 9b (Wnt9b) immunohistochemistry in the cytologic diagnosis of metastatic breast carcinoma
    Baykara, Yigit
    Lu, Shaolei
    Yang, Dongfang
    Wang, Yihong
    Yakirevich, Evgeny
    Hacking, Sean
    Pisharodi, Latha
    Maleki, Sara
    [J]. VIRCHOWS ARCHIV, 2023,
  • [9] A PROMOTOR VARIANT IN WNT9B IS A CANDIDATE IN A CASE WITH FEMORAL FACIAL SYNDROME
    Rope, A.
    Marvin, C.
    Chong, J.
    Buckingham, K.
    Shively, K.
    Bamshad, M.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (01) : 484 - 485
  • [10] Genetic variation in WNT9B increases relapse hazard in multiple sclerosis
    Vandebergh, M.
    Andlauer, T. F. M.
    Zhou, Y.
    Mallants, K.
    Held, F.
    Aly, L.
    Taylor, B. V.
    Hemmer, B.
    Dubois, B.
    Goris, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 48 - 49